Genomind's Series A Round

Genomind raised a round of funding on April 09, 2014. Investors include Claritas Capital.

Genomind is a personalized medicine company committed to the discovery of the underlying causes of neuropsychiatric disorders and supporting the development of personalized medicine that improves pati…

Articles about Genomind's Series A Round: